Comparative study of the inhibitory effect of antidepressants on cholinesterase activity in Bungarus sindanus (krait) venom, human serum and rat striatum

References

• A Chatonnet, and O Lockridge. (1989). Comparision of butyrylcholinestrase and acetylcholinestrase. J Biochem 260:625–634.
   Web of Science ®Google Scholar
• M Ekholm. (2001). Predicting relative binding free energies as substrate and inhibitors of acetyl and butyrylcholinestrase. J Mol Structure 572:25–34.
   Web of Science ®Google Scholar
• JP Changeux. (1966). Response of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs. Mol Pharmacol 2:369–392.
   PubMed Web of Science ®Google Scholar
• DJ Epstein, HA Berman, and P Taylor. (1979). Ligand-induced conformational changes in acetylcholinesterase investigated with fluorescence phosphonates. Biochemistry 18:4749–4754.
   PubMed Web of Science ®Google Scholar
• KR Dave, AR Syal, and SS Katyare. (2000). Tissue cholinesterases. A comparative study of their kinetic properties. Z Naturforsch 55:100–108.
   Google Scholar
• CA Prody, D Zevin-Sonkin, A Gnatt, O Goldberg, and H Soreq. (1987). Isolation and characterization of full lenght cDNA clones coding for cholinestrase from fetal human tissues. Proc Natl Acad Sci USA 84:3555–3559.
   PubMed Web of Science ®Google Scholar
• DJ Ecobicon, and AM Corneau. (1973). Pseudocholinestarase of mammalian plasma: Physichemical properties and organophosphate inhibition in eleven species. Toxicol Appl Pharmacol 24:29–100.
   Google Scholar
• B Li, JA Stribley, A Ticu, W Xie, LM Schopfer, P Hammond, S Brimijoin, SH Hinrichs, and O Lockridge. (2000). Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75:1320–1331.
   PubMed Web of Science ®Google Scholar
• V Chaliani, D Derr, B Earls, E Schmell, and T August. (1989). Purification and partial amino acid sequence analysis of human erythrocyte acetylcholinesterase. FEBS Lett 247 (2):279–282.
   PubMed Web of Science ®Google Scholar
• T Szegletes, WD Mallander, PJ Thomas, and TL Rosenberry. (1999). Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis: Substrate inhibition arises as a secondary effect. Biochemistry 38:122–133.
   PubMed Web of Science ®Google Scholar
• G Benzi, and A Moretti. (1998). Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?. Eur J Pharmacol 346:1–13.
   PubMed Web of Science ®Google Scholar
• Y Bourne, P Taylor, and P Marchot. (1995). Acetylcholinesterase inhibition by fasciculin, crystal structure of the complex. Cell 83:503–512.
   PubMed Web of Science ®Google Scholar
• HS Bawaskar, and PH Bawaskar. (2004). Envenoming by the common krait (Bungarus caeruleus) and Asian cobra (Naja naja): Clinical manifestations and their management in a rural setting. Wilderness Environ Med 15 (4):257–266.
   PubMed Web of Science ®Google Scholar
• Y Frobert, C Créminon, X Cousin, M Rémy, J Chatel, S Bon, C Bom, and J Grassi. (1997). Acetylcholinesterases from Elapidae snake venoms: Biochemical, immunological and enzymatic characterization. Biochim Biophys Acta 1339:253–267.
   PubMed Web of Science ®Google Scholar
• Créminon Cousin X, J Grassi, K Méflah, G Cornu, B Saliou, S Bon, J Massoulié, and C Bon. (1996). Acetylcholinesterase from Bungarus venom: A monomeric species. FEBS Lett 387:196–200.
   PubMed Web of Science ®Google Scholar
• CK Barcellos, MRC Schetinger, RD Dias, and JJF Sarkis. (1998). In vitro effect of central nervous system active drugs on the ATPase—ADPase activity and acetylcholinesterase activity from cerebral cortex of adult rats. Gen Pharmacol 31:563–567.
   PubMedGoogle Scholar
• TC Müller, JBT Rocha, VM Morsch, RT Neis, and MRC Schetinger. (2002). Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity. Biochim Biophys Acta 1587:92–98.
   PubMed Web of Science ®Google Scholar
• N Nunes-Tavares, AN Matta, CMB Silva, GMN Araújo, SRW Louro, and A Hassón-Voloch. (2002). Inhibition of acetylcholinesterase from Electrophorus electricus by tricyclic antidepressants. Int J Biochem Cell Biol 34:1071–1079.
   PubMed Web of Science ®Google Scholar
• M Bourin, P Chue, and C Guillon. (2001). Paroxetine. a review. CNS Drug Rev 7:25–47.
   PubMedGoogle Scholar
• GL Ellman, KD Courtney, JrV Andres, and RM Featherstone. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
   PubMed Web of Science ®Google Scholar
• JBT Rocha, T Emanuelli, and ME Pereira. (1993). Effects of early under nutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol Exp 53:431–437.
   PubMedGoogle Scholar
• MM Bradford. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• H Lineweaver, and D Burk. (1934). The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666.
   Web of Science ®Google Scholar
• BH Hofstee. (1952). On the evaluation of the constant Vm and constant Km enzyme reactions. Science 116:329–331.
   PubMed Web of Science ®Google Scholar
• JE Dowd, and DS Riggs. (1965). A comparison of estimates of Michaelis menten kinetic constants from various linear transformations. J Biol Chem 240:863–869.
   PubMed Web of Science ®Google Scholar
• M Dixon, EC Webb. Enzyme Kinetics. 2nd ed. London UK: Longman; (1964). 54.
   Google Scholar
• M Ahmed, JBT Rocha, CM Mazzanti, AL Morsch, D Cargnelutti, M Corrêa, V Loro, VM Morsch, and MRC Schetinger. (2007). Malathion, carbofuran and paraquat inhibit Bungarus sindanus (krait) venom acetylcholinesterase and human serum butyrylcholinesterase in vitro. Ecotoxicology 16 (4):363–369.
   PubMed Web of Science ®Google Scholar
• M Ahmed, JBT Rocham, M Corrêa, CM Mazzanti, RF Zanin, AL Morsch, VM Morsch, and MRC Schetinger. (2006). Inhibition of two different cholinesterases by tacrine. Chem Biol Interact 162:165–171.
   PubMed Web of Science ®Google Scholar
• DK Lahiri, JT Rogers, K Sambamurti, and NH Greig. (2004). Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Des 10:3111–3119.
   PubMed Web of Science ®Google Scholar
• JT O'Brien, and CG Ballard. (2001). Drugs for Alzheimer's disease. Br Med J 323:123–124.
   PubMed Web of Science ®Google Scholar
• SH Snyder, and HI Yamamura. (1977). Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 34:236–239.
   PubMed Web of Science ®Google Scholar
• TL Rosenberry, JL Johnson, B Cusack, JL Thomas, S Emani, and KS Venkatasubban. (2005). Interaction between the peripheral site and the acylation site in acetylcholinesterase. Chem Biol Interact 157–158:181–189.
   PubMed Web of Science ®Google Scholar
• S Marone, I Rozas, and DF Weaver. (1999). Theoretical structuralanalyses of tricyclic neuroactive drugs: Quantum pharmacologic descriptors for clustering anticonvulsant, antidepressant, and antipsychotic activities. J Mol Struct 467:25–30.
   Web of Science ®Google Scholar
• M Harel, I Schalk, L Ehret-Sabatier, F Bouet, M Goeldner, C Hirth, P Axelsen, I Silman, and JL Sussman. (1993). Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci USA 9031:9035.
   Google Scholar
• J Massoulié, L Pezzementi, S Bom, E Krejci, and EF Vallette. (1993). Molecular and cellular biology of cholinesterases. Prog Neurobiol Rev 41:31–91.
   PubMed Web of Science ®Google Scholar